-
Step Pharmaceuticals four-price influenza virus lysing vaccine approved for clinical trials
Time of Update: 2021-03-08
January 4, Step Pharmaceuticals announced that its controlling subsidiary, Zhejiang Tianyuan Biopharmaceutical Co., Ltd., had recently received a "Drug Clinical Trial Approval Notice" for the four-price influenza virus lysed vaccine approved by the State Drug Administration.
-
Ted Pharmaceuticals Pari osteobolicol injections are approved for drug registration
Time of Update: 2021-03-08
. Pali osteoporosisol is the latest generation of selective vitamin D-receiving excitants, combined with vitamin D-recipients to effectively reduce thyroid hormone (PTH), which is delivered through hemodialysis pathopathy to treat secondary thyroid
-
How will the anti-corruption in the field of pharmaceutical purchase and sale deepen?
Time of Update: 2021-03-08
of the drugs selected are high blood pressure, mental illness, viral hepatitis, malignant tumors and other chronic diseases and major diseases, long-term drug burden is very heavy. By taking the purchase of significantly reduce the price of drugs
-
The new crown inactivated vaccine of Koxing Zhongwei, a pharmaceutical speed-reading agency, was approved for sale in China
Time of Update: 2021-03-08
the launch of an innovative prescription medical device developed by Signal Medical Technologies on February 6, the FDA announced that it had approved the launch of an innovative prescription medical device developed by Signifier Medical Technologies
-
12 new class 1 drug batch clinical, from Sanofi, Yingpai Pharmaceuticals and other companies | Cde...
Time of Update: 2021-03-08
May 2020, the drug has been approved clinically in the United States for the treatment of IDH1 mutations in solid tumors including advanced bile tube cancer, cartilage sarcoma and glioma.
-
First Sound Pharmaceuticals has welcomed two key products in the third quarter
Time of Update: 2021-03-08
in the National Health Insurance Drug List from 2017. In the third quarter of this year, the first sound medicine industry ushered in two key products. These include the company's 13 years of independent research and development
-
CRO's leading company, Pharmaceuticals, announced the acquisition of a 60% stake in Mingjie Pharmaceuticals
Time of Update: 2021-03-08
of drugs, better help customers shorten the research and development cycle of new drugs, and achieve the great vision of 'making the world a drug that is not difficult to do, a disease that is difficult to treat'." According
-
Stone Pharmaceutical Group "first-in-class" antibody new drug approved clinically
Time of Update: 2021-03-08
On December 1st, Stone Pharmaceutical Group announced that its subsidiary's application for a clinical trial of alMB-0166, a new class 1 drug, had been approved by the State Drug Administration of China (NMPA) to conduct clinical
-
Ering Pharmaceuticals Semi-Annual Report Announces 50.35% YoY Increase in Operating Income
Time of Update: 2021-03-08
In the research and development and production of patented Chinese medicine at the same time, Toling Pharmaceuticals to promote "zero-level prevention", and actively lay out the large health industry.
-
Active withdrawal of the network or for the pharmaceutical company's 2020 performance "buried thunder"
Time of Update: 2021-03-08
May 25, Shanxi Province drug bidding procurement network hung out two notices, including Chenxin Pharmaceuticals, Chengdu Teo Pharmaceutical Group, Shi Pharmaceutical Group, Ha Pharmaceutical Group, Shenwei Pharmaceuticals and other 25
-
Zhongsheng Pharmaceuticals intends to contribute $515 million to Cosing Zhongwei
Time of Update: 2021-03-08
On December 7, China Biopharmaceuticals announced that hong Kong Jun-Kel Co., Ltd., a wholly-owned subsidiary, had entered into an agreement to invest $515 million in beijing-based Kexing Zhongwei Biotechnology Co., Ltd. for further
-
National collection series (third) large-scale domestic pharmaceutical enterprises continue to lead
Time of Update: 2021-03-08
in the collection of the past "Buddhist" attitude, positive quotations, such as Fessen Yuscabi propofol medium / long-chain fat milk injection and Sanofi's ammonia pills, the price reduction of more than 80%, more than the local pharmaceutical companies
-
The three major pharmaceutical central enterprises have all entered the bureau of the blood products field pattern or change
Time of Update: 2021-03-07
of high-quality targets. Hu Boxin, chief pharmaceutical analyst at Dongxing Securities, believes that Boya Bio should also see the strength of Boya Bio as a quasi-leader of blood products than the "noise" from the outside world.
-
China Resources Pharmaceuticals intends to acquire a controlling stake in Boya Biopharmaceutical Group
Time of Update: 2021-03-07
China Resources Pharmaceutical Holdings intends to acquire a controlling stake in the target company, and the terms of the proposed acquisition will not be implemented until further negotiations between China Resources Pharmaceutical Holdings and the seller.
-
AI new pharmaceutical company Fermizi Technology completed a cumulative hundreds of millions of yuan A round of financing
Time of Update: 2021-03-07
Fermizi using AI technology to drive new drug research and development to complement China's global new drug research and development of this backward status quo, the more China's backward industries have the opportunity, any future industry has
-
Sapp Ace will list its subsidiary Strong Body Pharmaceuticals
Time of Update: 2021-03-07
to transfer 100% of the shares held by Strong Body Pharmaceuticals by public listing on the Shanghai Joint Property Exchange, with the first listing price being 100% equity evaluation value of Strong Pharmaceuticals. Data show
-
Large-scale pharmaceutical industry park project settled in Kunming high-tech zone
Time of Update: 2021-03-07
development of the pharmaceutical sector, improve the overall asset management efficiency, enrich upstream and downstream business resources, optimize the industrial structure, practice the development of a new positioning, write a new chapter of Yunnan City
-
Magic Pharmaceuticals intends to transfer a 30.16 per cent stake in Jilin Kangzheng
Time of Update: 2021-03-07
, Magic Pharmaceuticals announced today that its wholly-owned subsidiary, Magic Pharmaceuticals, intends to transfer its 30.16 percent stake in Jilin Kangzheng, the controlling sun company.
-
Global Pharmaceutical CEO Compensation PK: AZ annual salary of 140 million yuan Roche down salary ...
Time of Update: 2021-03-07
02 Roche/Novarter CEO's annual salary doubles, a year-end award for the base salary 2020 new crown pandemic raging around the world, seriously affecting global economic growth, most companies are struggling, layoffs and pay cuts.
-
More than $35 billion! 278 pharmaceutical companies invested in research and development exposure
Time of Update: 2021-03-07
Xiang Xue Pharmaceutical invested 193 million yuan in research and development, an increase of 294.06 percent over the same period last year, accounting for 10.65 percent of operating income.
